Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation

Insights into Imaging

Volumn 6, Issue 6, 2015, Pages 611-630

  Panebianco, V ^a   Barchetti, F ^a   Barentsz, J ^b   Ciardi, A ^a   Cornud, F ^c   Futterer, J ^b   Villeirs, G ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Institut Cochin   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Differential diagnosis; mp MRI; Pitfalls; Prostate; Prostate MRI

Indexed keywords

EID: 84947793458     PISSN: None     EISSN: 18694101     Source Type: Journal    
DOI: 10.1007/s13244-015-0426-9     Document Type: Review

References (65)

1. Walz J, Burnett AL, Costello AJ, Ja E, Graefen M, Guillonneau B et al (2010) Acritical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection incandidates for radical prostatectomy. Eur Urol 57:179–192
2. Panebianco V, Barchetti F, Sciarra A, Ciardi A, Indino EL et al (2015) Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol 33:17.e1–7
3. Fütterer JJ (2007) MR imaging in local staging of prostate cancer. Eur J Radiol 63:328–334
4. Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66
5. Colleselli D, Hennenlotter J, Schilling D et al (2011) Impact of clinical parameters on the diagnostic accuracy of endorectal coil MRI for the detection of prostate cancer. Urol Int 86:393–398
6. Hambrock T, Fütterer JJ, Huisman HJ et al (2008) Thirty two- channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 43:686–694
7. Franiel T, Lüdemann L, Rudolph B et al (2008) Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol 43:481–487
8. Tan CH, Wei W, Johnson V et al (2012) Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 199:822–829
9. Wu LM, Xu JR, Gu HY et al (2012) Usefulness of diffusion weighted magnetic resonance imaging in the diagnosis of prostate cancer. Acad Radiol 19:1215–1224
10. Morgan VA, Riches SF, Giles S et al (2012) Diffusion weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol 198:596–602
11. Heijmink SW, Scheenen TW, Fütterer JJ et al (2007) Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy. Invest Radiol 42:420–427
12. Caivano R, Cirillo P, Balestra A et al (2012) Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences. J Med Imaging Radiat Oncol 56:606–616
13. Vilanova JC, Barceló-Vidal C, Comet J et al (2011) Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 196:W715–W722
14. Rischke HC, Schäfer AO, Nestle U et al (2012) Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil. Radiat Oncol 7:185
15. Chen YJ, Chu WC, Pu YS et al (2012) Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer. J Magn Reson Imaging 36:912–919
16. Verma S, Turkbey B, Muradyan N et al (2012) Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol 198:1277–1288
17. Panebianco V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V et al (2013) Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol 23(6):1745–1752
18. Vargas HA, Wassberg C, Akin O, Hricak H (2012) MR imaging of treated prostate cancer. Radiology 262(1):26–42
19. Liberman L, Menell JH (2002) Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 40(3):409–430
20. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22(4):746–757
21. Rosenkrantz AB, Taneja SS (2014) Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 202(1):109–120
22. Heijmink SW, Fütterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-- comparison of image quality, localization, and staging performance. Radiology 244(1):184–195
23. Oto A, Kayhan A, Jiang Y et al (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723
24. McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897–906
25. Greene DR, Wheeler TM, Egawa S et al (1991) A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146(4):1069–1076
26. Shannon BA, McNeal JE, Cohen RJ (2003) Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour. Pathology 35(6):467–471
27. Akin O, Sala E, Moskowitz CS et al (2006) Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239(3):784–792
28. Kim CK, Park BK, Han JJ et al (2007) Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr 31(3):449–454
29. Tamada T, Sone T, Jo Y et al (2008) Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 28(3):720–726
30. Kim CK, Park BK, Lee HM, Kwon GY (2007) Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 42(12):842–847
31. Sato C, Naganawa S, Nakamura T et al (2005) Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21(3):258–262
32. Hoeks CM, Hambrock T, Yakar D, de Kaa CA H, Feuth T, Witjes JA et al (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266(1):207–217
33. Bour L, Schull A, Delongchamps NB, Beuvon F, Muradyan N, Legmann P et al (2013) Multiparametric MRI features of granulomatous prostatitis and tubercular prostate abscess. Diagn Interv Imaging 94(1):84–90
34. Bouyé S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A (2009) Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate 69(1):105–113
35. Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional T1- weighted magnetization-prepared-rapid gradient- echo sequence. AJR Am J Roentgenol 167:1503–1507
36. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–2499
37. Young HH (1905) VIII. Conservative perineal prostatectomy: the results of two years’ experience and report of seventy-five cases. Ann Surg 41(4):549–557
38. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR (2004) The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22(11):2141–2149
39. Bianco FJ Jr, Scardino PT, Eastham JA (2005) Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66(5 Suppl):83–94
40. Eastham JA, Scardino PT, Kattan MW (2008) Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol 179(6):2207–2210, discussion 2210–2211
41. Patel VR, Coelho RF, Chauhan S et al (2010) Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon. BJU Int 106(5):696–702
42. Cirillo S, Petracchini M, Scotti L et al (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19(3):761–769
43. Sella T, Schwartz LH, Swindle PW et al (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231(2):379–385
44. Sella T, Schwartz LH, Hricak H (2006) Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance. AJR Am J Roentgenol 186(2):539–546
45. Hricak H, Carrington BM (1991) MRI of the pelvis: a text atlas. Martin Dunitz, London
46. Sciarra A, Panebianco V, Salciccia S et al (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54(3):589–600
47. Sfoungaristos S, Kontogiannis S, Perimenis P (2013) Early continence recovery after preservation of maximal urethral length until the level of verumontanum during radical prostatectomy: primary oncological and functional outcomes after 1 year of follow-up. Biomed Res Int 2013:426208
48. Muezzinoglu B, Erdamar S, Chakraborty S, Wheeler TM (2001) Verumontanum mucosal gland hyperplasia is associated with atypical adenomatous hyperplasia of the prostate. Arch Pathol Lab Med 125(3):358–360
49. Cellini N, Morganti AG, Mattiucci GC et al (2002) Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 53(3):595–599
50. Pucar D, Hricak H, Shukla-Dave A et al (2007) Clinically signifi cant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 69(1):62–69
51. Pucar D, Shukla-Dave A, Hricak H et al (2005) Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 236(2):545–553
52. Rouvière O, Valette O, Grivolat S et al (2004) Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor—correlation with biopsy findings. Urology 63(5):922–927
53. Kim CK, Park BK, Lee HM (2009) Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 29(2):391–397
54. Akin O, Gultekin DH, Vargas HA et al (2011) Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. Eur Radiol 21(9):1970–1978
55. Mueller-Lisse UG, Swanson MG, Vigneron DB et al (2001) Time-Dependent Effects of Hormone-Deprivation Therapy on Prostate Metabolism as Detected by Combined Magnetic Resonance Imaging and 3D Magnetic Resonance Spectroscopic Imaging. Magn Reson Med 46:49–57
56. Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J et al (2014) The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int 113(2):218–227
57. Kalbhen CL, Hricak H, Shinohara K et al (1996) Prostate carcinoma: MR imaging findings after cryosurgery. Radiology 198:807–811
58. Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C (2008) MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 246:833–844
59. Haider MA, Davidson SR, Kale AV et al (2007) Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology 244:196–204
60. Parivar F, Hricak H, Shinohara K (1996) Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and threedimensional proton magnetic resonance spectroscopy. Urology 48:594–599
61. Rouvière O, Lyonnet D, Raudrant A et al (2001) MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 40:265–274
62. Kim CK, Park BK, Lee HM, Kim SS, Kim E (2008) MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 190(5):1180–1186
63. Rosenkrantz AB, Scionti SM, Mendrinos S, Taneja SS (2011) Role of MRI in minimally invasive focal ablative therapy for prostate cancer. AJR Am J Roentgenol 197(1):W90–W96
64. Kim CK, Park BK, Lee HM, Kim SS, Kim E (2008) MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR 190:1180–1186
65. Yang DM, Jung DH, Kim H et al (2004) Retroperitoneal cystic masses: CT, clinical, and pathologic findings and literature review. RadioGraphics 24(5):1353–1365